These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22583777)

  • 1. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.
    Yao C; Wu S; Li D; Ding H; Wang Z; Yang Y; Yan S; Gu Z
    Mol Oncol; 2012 Aug; 6(4):392-404. PubMed ID: 22583777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma.
    Ren X; Su C
    Mol Med Rep; 2020 Sep; 22(3):2183-2190. PubMed ID: 32705189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furowanin A Exhibits Antiproliferative and Pro-Apoptotic Activities by Targeting Sphingosine Kinase 1 in Osteosarcoma.
    Wei K; Sun H; Chen X; Chen Q; Li Y; Wu H
    Anat Rec (Hoboken); 2019 Nov; 302(11):1941-1949. PubMed ID: 31197942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma.
    Hazar-Rethinam M; de Long LM; Gannon OM; Topkas E; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Simpson F; Endo-Munoz L; Saunders NA
    Clin Cancer Res; 2015 Jan; 21(2):417-27. PubMed ID: 25411162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic value of SC66 in human renal cell carcinoma cells.
    Xu M; Wang Y; Zhou LN; Xu LJ; Jin ZC; Yang DR; Chen MB; Zhu J
    Cell Death Dis; 2020 May; 11(5):353. PubMed ID: 32393791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.
    Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M
    Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
    Li W; Li J; Wang Y; Zhang K; Li N; Tian Z; Ni B; Wang H; Ruan Z
    Oncotarget; 2016 Dec; 7(49):80586-80598. PubMed ID: 27811359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition.
    Liao YX; Lv JY; Zhou ZF; Xu TY; Yang D; Gao QM; Fan L; Li GD; Yu HY; Liu KY
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34080667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5,7-Dihydroxy-4'-methoxyisoflavone induces apoptosis by inhibiting the ERK and Akt pathways in human osteosarcoma cells.
    Lu X; Zhao J; Li T; Huang M; Liang J; Wei W
    Connect Tissue Res; 2015 Feb; 56(1):59-64. PubMed ID: 25363142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo.
    Zhai L; Sun N; Han Z; Jin HC; Zhang B
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):274-80. PubMed ID: 26505795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proanthocyanidin B2 inhibits proliferation and induces apoptosis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Wu X; Yu H; Zhou H; Li Z; Huang H; Xiao F; Xu S; Yang Y
    J Cell Mol Med; 2020 Oct; 24(20):11960-11971. PubMed ID: 32914567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
    Xu L; Zhang Y; Gao M; Wang G; Fu Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells.
    Yang YL; Ji C; Cheng L; He L; Lu CC; Wang R; Bi ZG
    Cancer Sci; 2012 Aug; 103(8):1538-45. PubMed ID: 22594559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
    Hu T; Fei Z; Su H; Xie R; Chen L
    Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells.
    Lu PH; Chen MB; Liu YY; Wu MH; Li WT; Wei MX; Liu CY; Qin SK
    Oncotarget; 2017 Apr; 8(14):22800-22810. PubMed ID: 28206952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
    LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
    Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase 1 is a relevant molecular target in gastric cancer.
    Fuereder T; Hoeflmayer D; Jaeger-Lansky A; Rasin-Streden D; Strommer S; Fisker N; Hansen BJ; Crevenna R; Wacheck V
    Anticancer Drugs; 2011 Mar; 22(3):245-52. PubMed ID: 21360847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting sphingosine kinase-1 to inhibit melanoma.
    Madhunapantula SV; Hengst J; Gowda R; Fox TE; Yun JK; Robertson GP
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):259-74. PubMed ID: 22236408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.